Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Cann Group ( (AU:CAN) ) is now available.
Cann Group Limited announced the quotation of 7,676,567 fully paid ordinary securities on the Australian Securities Exchange (ASX), effective April 30, 2025. This move is expected to enhance the company’s capital structure and provide additional liquidity, potentially strengthening its market position and offering more opportunities for stakeholders.
More about Cann Group
Cann Group Limited operates in the pharmaceutical industry, focusing on the cultivation and production of medicinal cannabis products. The company is dedicated to advancing the use of cannabis for medical purposes and holds a significant position in the Australian market.
YTD Price Performance: 80.0%
Average Trading Volume: 300
Technical Sentiment Signal: Buy
Current Market Cap: $6.2M
For a thorough assessment of CAN stock, go to TipRanks’ Stock Analysis page.